Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 424/4 | Other Identifier | KEMRI SERU |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kenya Medical Research Institute | OTHER |
| Jomo Kenyatta University of Agriculture and Technology | OTHER |
| International Centre of Insect Physiology and Ecology (ICIPE) | OTHER |
Not provided
Not provided
Not provided
The goal of this intervention study is to learn about the impact of household flooring on health in rural Kenya, and test whether providing an improved (cement stabilised, washable) floor improves the health of children and their care providers.
The main questions the study aims to answer are:
The study will involve a trial, where half of the recruited households will be randomly chosen to receive the new floor in addition to some support on how to care for the floor and keep it clean. The other half of households will not receive anything at first, but at the end of the research project will also receive a new floor.
Before the new floors are installed, the investigators will make several assessments in all study households. These will include a survey to measure household characteristics; a stool survey, to measure how many people are infected with diarrhoea-causing microorganisms and parasitic worms; a jigger flea examination among children; wellbeing assessments among children and caregivers; and soil sampling to identify microorganisms on the floor of the household.
When households receive the new floor, participants will have to move out of their house for up to 7 days during installation. Participants will also be asked to attend some group meetings to discuss ways of taking care of the floor and keeping it clean.
Assessments will be repeated 12 months after the floor has been delivered, and additional interviews will be held with a small number of randomly selected participants. Throughout the 12 months following delivery of the intervention, investigators will make unannounced visits to households to check the condition of the floor. Participants will also be offered treatment for parasitic worm infections after assessments have been completed at the start and end of the project.
Earthen floors are often damp or dusty and difficult to clean, providing an ideal environment for faecal pathogens and parasites. Cross-sectional studies have revealed associations between household flooring and health outcomes, but robust experimental evidence is scant. This study will evaluate the impact of an improved household flooring intervention on enteric infections, soil-transmitted helminth (STH) infections, and tungiasis through implementation of a cluster-randomised trial in two rural settings in Kwale and Bungoma Counties, Kenya.
The primary aim of this study is to evaluate the effectiveness of an improved flooring intervention in reducing the burden of enteric infections, STH and tungiasis in participating households through implementation of a randomised controlled trial (RCT) in two distinct settings in rural Kenya. The primary objectives are to quantify impact on the prevalence of enteric infections, STH infections, and tungiasis. Secondary objectives include assessing impact on the wellbeing of caregivers and children, self-report gastrointestinal illness in children, and the extent to which entero-pathogen and parasitic contamination of floors is reduced within the home. We will also examine the differential effects across community and household contexts (including water, sanitation, and hygiene (WASH) infrastructure, animal husbandry, user adherence and study site). Lastly, we deliver a process evaluation to determine the practicality, acceptability, costs, and durability of the improved flooring intervention and how environmental, installation, and use factors affect these.
In total, 440 clusters (households) across both sites are allocated to either control or intervention group, in which a low-cost, sealed, washable cement-based floor is installed in all eligible buildings of the dwelling, alongside a floor care guide provided during an induction meeting. Prevalence of enteric infections in children under 5 years will be assessed via stool surveys and PCR; prevalence of tungiasis infection in children 1-14 years based on clinical exam; and prevalence of STH infection in all household members over 1 year assessed via Kato-Katz. Following the 12-month implementation period and final assessments, control households will be offered improved floors.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention (improved floor) | Experimental |
|
|
| Control (rudimental floor) | Active Comparator |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sealed washable floor plus behaviour change | Other | Replacement of rudimentary floors with a cement stabilised floor in all rooms in the dwelling |
|
| Measure | Description | Time Frame |
|---|---|---|
| Enteric infections | Prevalence of enteric infections (detected through PCR) in children under 5 years old will be assessed using cross-sectional stool surveys including all enrolled children under 5 years before installation of floors and 12 months after receiving the floors. Pathogens to be identified from those observed at baseline using a multipathogen panel on a subset of 100 samples. | 12 months |
| Tungiasis infections | Prevalence of tungiasis (detected through clinical examination of hands and feet) in children under 15 years old will be assessed using cross-sectional clinical assessment surveys including all enrolled children under 15 years before installation of floors and 12 months after receiving the floors. | 12 months |
| STH infections | Prevalence of at least one STH infection (hookworm, ascaris and trichuris infections; detected through kato katz) in all household members 12 months and older will be assessed using cross-sectional stool surveys including all enrolled people over 12 months of age before installation of floors and 12 months after receiving the floors. | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Gastrointestinal illness | Prevalence of gastrointestinal illness in children under 5 years - assessed in both study arms based on caregiver reported symptoms | 12 months |
| Intensity and severity of tungiasis |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rachel Pullan, PhD | London School of Hygiene and Tropical Medicine | Principal Investigator |
| Ulrike Fillinger, PhD | icipe | Principal Investigator |
| Charles Mwandawiro, PhD | Kenya Medical Research Institute | Principal Investigator |
| James Wambua KALULI, PhD | JKUAT | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dzombo ward | Kwale | Kwale County | Kenya |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40480665 | Derived | Halliday KE, Kepha S, Legge H, Allen E, Dreibelbis R, Elson L, Kakoi BK, Mcharo C, Muli S, Mwongeli J, Njomo D, Njoroge MM, Ochwal V, Oswald WE, Rono M, Safari TK, Filinger U, Kaluli JW, Mwandawiro CS, Pullan RL. Evaluating impacts of improved flooring on enteric and parasitic infections in rural households in Kenya: study protocol for a cluster-randomised controlled trial. BMJ Open. 2025 Jun 6;15(6):e090464. doi: 10.1136/bmjopen-2024-090464. |
Not provided
Not provided
Data collected from this study and underlying each article (text, tables, figures, and appendices), including quantitative, de-identified, individual participant data and a data dictionary, will be made available following publication of the article(s).
The quantitative, individual, de-identified, participant data that underlie the results reported in each published article (text, tables, figures, and appendices) will be made available within three months of publication of each article, with no end date.
The data will be made available to members of the scientific and medical community for non-commercial use only, upon email request to the corresponding author. Written proposals will be assessed by members of the SABABU Trial Group and a decision made about the appropriateness of the use of data. Data will be stored at LSHTM Data Compass, the London School of Hygiene & Tropical Medicine digital data repository The data will be available to anyone who wishes to access the data through the LSHTM Data Compass, the London School of Hygiene & Tropical Medicine digital data repository.
Not provided
Not provided
| ID | Term |
|---|---|
| D006725 | Hookworm Infections |
| D014257 | Trichuriasis |
| D058285 | Tungiasis |
| ID | Term |
|---|---|
| D017206 | Strongylida Infections |
| D017190 | Secernentea Infections |
| D009349 | Nematode Infections |
| D006373 | Helminthiasis |
Not provided
Not provided
| ID | Term |
|---|---|
| D015766 | Albendazole |
| D013812 | Therapeutics |
| ID | Term |
|---|---|
| D002219 | Carbamates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
Not provided
Not provided
Single Group Assignment
Not provided
Not provided
Not provided
Not provided
| Behaviour change intervention | Behavioral | Support for behaviour change through 'floor clubs' and the provision of printed guides |
|
| Routine deworming | Drug | Treatment of all household members for STH infections (400 mg albendazole in those aged 24 months and above; 200 mg albendazole in those aged 12-23 months) |
|
|
| treatment for tungiasis | Procedure | Treatment of tungiasis in those affected by heavy infections (at 0 and 12 months) according to county Department of Health recommendations |
|
Intensity of tungiasis and severity of acute and chronic tungiasis-associated pathology in children <15 years - assessed using clinical severity scores (range: 0-110, high scores indicating increased severity/worse outcome)
| 12 months |
| Quality of Life for children aged 8 to 14 years | Quality of Life assessed in children ages 8 to 14 years in both arms using the standardised EQ5D-Y (EuroQol 5-dimension health-related quality of life tool for children; values are anchored at 1 (full health) and 0 (a state as bad as being dead)) | 12 months |
| Quality of Life and subjective wellbeing in primary caregivers | Quality of Life assessed in primary caregivers in both arms using the standardised EQ5D tool (EuroQol 5-dimension health-related quality of life tool for adults; values are anchored at 1 (full health) and 0 (a state as bad as being dead)) | 12 months |
| Prevalence of Ascaris lumbricoides infection | Ascaris lumbricoides (roundworm) infection prevalence in all household members >1 year assessed using Kato Katz | 12 months |
| Prevalence of hookworm infection | Hookworm infection prevalence in all household members >1 year assessed using Kato Katz | 12 months |
| Prevalence of Trichuris trichiura infection | T. trichiura (whipworm) infection prevalence in all household members >1 year assessed using Kato Katz | 12 months |
| Environmental contamination - enteric pathogens | Environmental contamination for human-specific and animal faecal markers - assessed from dust/soil samples from household cooking areas and living rooms using PCR. | 12 months |
| Environmental contamination - tungiasis | Contamination of floors with eggs, larvae, pupae and adults of T. penetrans - assessed through entomology soil surveys | 6 months |
| D010272 |
| Parasitic Diseases |
| D007239 | Infections |
| D017189 | Enoplida Infections |
| D017188 | Adenophorea Infections |
| D058267 | Flea Infestations |
| D004478 | Ectoparasitic Infestations |
| D012876 | Skin Diseases, Parasitic |
| D001562 |
| Benzimidazoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |